Precipio, Inc.PRPONASDAQ

52-Week Range4-30

3.90Current 26.9329.53

Want to monitor PRPO?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine.

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

ACP: Deteriorating Credit Market Decreases Appeal (Rating Downgrade)

XPeng Posts First-Ever Profit on Strong Sales, Margins

Smiths Group shares drop 6% despite strategic moves and capital returns

Best Value Stocks to Buy for March 20th

Super Micro Stock Plunges 19%. U.S. Alleges Employees Planned to Smuggle Chips to China.

Director/PDMR Shareholding

Gartner CEO: ‘It Can Take a Couple of Years' Before Investors See the Payoff

Hess Midstream: Spending Winding Down, Now Comes $850-$900 Million in Free Cash Flow

Nvidia CEO: $10 trillion company valuation absolutely possible

Cloudbreak Discovery shares climb as it details gold exploration plans in WA

Nvidia's 3 Key Catalysts Failed to Boost the Stock. This Big Hope Might.

Subsea7 Annual Report 2025

This $58 Billion Merger Is Creating the Most Unstoppable Oil and Gas Stock in America

Oil Pulls Back from Highs as Leaders Seek to Calm Markets

Hyundai to recall over 61,000 Palisade SUVs in US after fatal incident, NHTSA says

RITM Stock Near 52-Week Low Despite $100 Billion in Assets and a Blowout Quarter

Oil Prices Drop From $119 High. Why They May Have Hit a Ceiling as Iran Rally Fades.

Torrid Holdings Inc. (CURV) Q4 2025 Earnings Call Transcript

Traders give 65% odds of oil holding above $100 a barrel to end of March

Spire Global: A High-Growth Space Data Platform At An Inflection Point

About